CardioContrastWRAP:

The Role of Ionic, Low Osmolar Contrast Media (LOCM) for Thrombosis Reduction
in the Setting of PCI

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

July 1, 2009

Expiration Date:

July 1, 2011

Intended Audience:

This program is designed for interventional cardiologists and interventional radiologists.

Registration:

Enrollment for this DiseaseStateWRAP is complimentary, and clinicians are invited to participate in this CME-certified DiseaseStateWRAPs and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

The following program has been supported
by an independent medical educational grant
from Guerbet, LLC.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty:

Steven V. Manoukian, MD, FACC, FSCAI
Director, Cardiovascular Research
Sarah Cannon Research Institute
Medical Director for Cardiology Services
Clinical Services Group
Hospital Corporation of America (HCA)
Nashville, Tennessee

Faculty Disclosures:

Dr. Manoukian discloses that, in the past 12 months, he has been a consultant to Guerbet, LLC

Educational Objectives:

As a result of participating in this program, clinicians will:

• Learn about the role of contrast agents in the setting of PCI.

• Learn about the physical, chemical, and biological properties of contrast agents used in PCI and their potential impact on renal function, thrombosis,
  and bleeding.

• Learn how ionic properties, viscosity, and other chemical features may affect renal function and coagulation in the setting of PCI.

• Learn how to optimize selection of contrast agents in the cardiac catheterization laboratory in order to reduce potential adverse events.

• Learn how to initially risk stratify patients undergoing cath and determine which contrast agents may be uniquely suitable for specific patient subgroups.
  

Disclaimer:

Copyright © 2009 by CMEducation Resources, LLC and Pharmatecture, LLC All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this HealthWRAP reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this HealthWRAP is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this HealthWRAP is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This HealthWRAP is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This HealthWRAP is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved